UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

Molecular therapy, 2024-08, Vol.32 (8), p.2428-2428

Tregoning, John S.

2024

Volltextzugriff (PDF)

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Science translational medicine, 2015-08, Vol.7 (300), p.300ra127

2015

Volltextzugriff (PDF)

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Journal of virology, 2014-04, Vol.88 (8), p.4237-4250

2014

Volltextzugriff (PDF)

Respiratory syncytial virus infection and novel interventions

Nature reviews. Microbiology, 2023-11, Vol.21 (11), p.734-749

2023

Volltextzugriff (PDF)

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Volltextzugriff (PDF)

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

Nature communications, 2015-09, Vol.6 (1), p.8143-8143, Article 8143

2015

Volltextzugriff (PDF)

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Nucleic acids research, 2024-05, Vol.52 (9), p.4872-4888

2024

Volltextzugriff (PDF)

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

PloS one, 2014, Vol.9 (6), p.e100392

2014

Volltextzugriff (PDF)

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Volltextzugriff (PDF)

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Volltextzugriff (PDF)

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Journal of general virology, 2014-06, Vol.95 (Pt 6), p.1244-1254

2014

Volltextzugriff (PDF)

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Science translational medicine, 2015-08, Vol.7 (300), p.300ra126

2015

Volltextzugriff (PDF)

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Clinical and vaccine immunology, 2016-03, Vol.23 (3), p.189-195

2016

Volltextzugriff (PDF)

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The Journal of infectious diseases, 2020-06, Vol.221 (12), p.2050-2059

2020

Volltextzugriff (PDF)

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Pediatric research, 2015-11, Vol.78 (5), p.483-491

2015

Volltextzugriff (PDF)

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies

Cell reports (Cambridge), 2024-10, Vol.43 (10), p.114811, Article 114811

2024

Volltextzugriff (PDF)

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Immunological reviews, 2011-01, Vol.239 (1), p.149-166

Graham, Barney S.

2011

Volltextzugriff (PDF)

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.e637-e646

2024

Volltextzugriff (PDF)

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1362-1370

2017

Volltextzugriff (PDF)

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

The Journal of infectious diseases, 2024-09, Vol.230 (3), p.e647-e656

2024

Volltextzugriff (PDF)

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Science (American Association for the Advancement of Science), 2024-09, Vol.385 (6716), p.1484-1491

2024

Volltextzugriff (PDF)

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Nature (London), 2013-09, Vol.501 (7467), p.439-443

2013

Volltextzugriff (PDF)

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Cell host & microbe, 2022-01, Vol.30 (1), p.41-52.e5

2022

Volltextzugriff (PDF)

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.e153-e163

2016

Volltextzugriff (PDF)

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

Frontiers in immunology, 2024-06, Vol.15, p.1376395

2024

Volltextzugriff (PDF)

1 – 25 von 6.143

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.671)
Mit Volltextzugriff
(4.395)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.266)
Life Sciences & Biomedicine
(4.943)
Humans
(4.369)
Respiratory Syncytial Virus
(3.723)
Immunology
(3.100)
Animals
(2.165)
Infectious Diseases
(2.047)
Female
(1.982)
Infant
(1.867)
Respiratory Syncytial Viruses - Immunology
(1.774)
Respiratory Syncytial Virus Infections - Immunology
(1.640)
Microbiology
(1.510)
Biological And Medical Sciences
(1.487)
Male
(1.448)
Viruses
(1.303)
Virology
(1.196)
Infections
(1.138)
Child, Preschool
(1.090)
Mice
(1.085)
Medical Sciences
(1.055)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(5.518)
EZB Free E-Journals
(4.234)
Journals@Ovid Complete
(2.785)
Publisher or Other Site
(2.070)
Ingenta
(2.036)
IngentaConnect Journals
(1.559)
Oxford University Press Journals Current
(862)
Wiley Online Library - AutoHoldings Journals
(782)
Jstor Complete Legacy
(779)
Oxford Journals 2020 Medicine
(767)
Wiley Online Library Full Collection 2018
(587)
Springer Nature - Complete Springer Journals
(334)
Springer Nature - Connect here FIRST to enable access
(248)
Taylor & Francis Journals Auto-Holdings Collection
(237)
Taylor & Francis Current Content Access
(222)
Elsevier ScienceDirect Journals Complete
(194)
Taylor & Francis Online
(189)
Nexis Uni
(187)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(185)
BMJ Journals
(104)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(55)
... seit 30 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections

Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection

Respiratory syncytial virus infection and novel interventions

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

RNA-RNA interactions between respiratory syncytial virus and miR-26 and miR-27 are associated with regulation of cell cycle and antiviral immunity

Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

The race to make vaccines for a dangerous respiratory virus

Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults

Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease

Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children

The role of Th17 and Treg responses in the pathogenesis of RSV infection

Targeting RSV-neutralizing B cell receptors with anti-idiotypic antibodies

Biological challenges and technological opportunities for respiratory syncytial virus vaccine development

Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Mutating a flexible region of the RSV F protein can stabilize the prefusion conformation

Cross-neutralization of four paramyxoviruses by a human monoclonal antibody

Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

Filling two needs with one deed: a combinatory mucosal vaccine against influenza A virus and respiratory syncytial virus

Aktive Filter

Suchergebnisse filtern